Drugs / dimethylamino benzoylphenylurea
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00016354 | Mar 2001 → Aug 2004 | cancer of unknown primary site | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dimethylamino benzoylphenylurea | “A phase I study of dimethylamino benzoylphenylurea (BPU), a tubulin inhibitor, was performed using a weekly continuous schedule.” PMID 17084620 ↗ Nov 2006 |
| Known as | BPU | “A phase I study of dimethylamino benzoylphenylurea (BPU), a tubulin inhibitor, was performed using a weekly continuous schedule.” PMID 17084620 ↗ Nov 2006 |
| Action | Inhibit | “a tubulin inhibitor” PMID 17084620 ↗ Nov 2006 |
| Route | Oral | “Patients receive oral benzoylphenylurea (BPU) once weekly” NCT00016354 ↗ |